Loss of dopaminergic neurons in parkinsonism: Possible role of reactive dopamine metabolites

Journal of Neural Transmission, Supplement

Volumn , Issue 49, 1997, Pages 103-110

  Hastings, T G ^a,b   Zigmond, M J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE DERIVATIVE; NEUROTOXIN; REACTIVE OXYGEN METABOLITE; ANTIOXIDANT; DOPAMINE; LEVODOPA; OXIDOPAMINE;

DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; HUMAN; NERVE CELL LESION; NEUROPATHOLOGY; NEUROTOXICITY; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ANIMAL; INCIDENCE; MIDDLE AGED; NERVE CELL; PARKINSON DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; DOPAMINE; HUMANS; INCIDENCE; LEVODOPA; MIDDLE AGED; NEURONS; NEUROTOXINS; OXIDOPAMINE; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES;

EID: 0030612204     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6844-8_11     Document Type: Review

References (27)

1. Abercrombie ED, Bonatz AE, Zigmond MJ (1990) Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 525: 36-44
2. Agid Y, Ruberg M, Javoy-Agid F, et al (1993) Are dopaminergic neurons selectively vulnerable to Parkinson's disease? Adv Neurol 60: 148-163
3. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington: clinical morphological and neurochemical correlations. J Neurol Sci 20: 415-455
4. Chapman AG, Durmuller N, Lees GJ, Meldrum BS (1989) Excitoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres. Neurosci Lett 107: 256-260
5. Cohen G (1983) The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence. J Neural Transm [Suppl] 19: 89-103
6. Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381-389
7. Filloux F, Townsend JJ (1993) Pre- and post-synaptic neurotoxic effects of dopamin demonstrated by intrastriatal injection. Exp Neurol 119: 79-88
8. Fornstedt B, Carlsson A (1991) Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum. J Neurochem 56: 407-414
9. Fornstedt B, Rosengren E, Carlsson A (1986) Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine dopa and dopac in the brains of eight mammalian species. Neuropharmacol 25: 451-454
10. Fornstedt B, Pileblad E, Carlsson A (1990) In vivo autoxidation of dopamine in guinea pig striatum increases with age. J Neurochem 55: 655-659
11. Giovanni A, Liang LP, Hastings TG, Zigmond MJ (1995) The estimation of hydroxyl radical content in rat brain using salicylate: impact of methamphetamine. J Neurochem 64: 1819-1825
12. Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14: 633-643
13. Graham DG, Tiffany SM, Bell WR jr, Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine 6-hydroxydopamine and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 14: 644-653
14. Grisham MB, Perez VJ, Everse J (1987) Neuromelanogenic and cytotoxic properties of canine brainstem peroxidase. J Neurochem 48: 876-882
15. Halliwell B, Gutteridge JMC (1985) Oxygen radicals and the nervous system. Trends Neurosci 8: 22-26
16. Hastings TG (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem 64: 919-924
17. 3H-dopamine: impact of ascorbic acid and gluthathione. J Neurochem 63: 1126-1132
18. Hastings TG, Lewis DA, Zigmond MJ (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Sci USA 93: 1956-1961
19. Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334: 345-348
20. Johnson M, Stone DM, Hanson GR, Gibb JW (1987) Role of dopaminergic nigrostriatal pathway in metamphetamine-induced depression of the neostriatal serotonergic system. Eur J Pharmacol 135: 231-234
21. Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Agid Y (1992) Is the vulnerability of neurons in substantia nigra of patients with Parkinson's disease related to their neuromelanin content? J Neurochem 59: 1080-1089
22. Kish SJ, Morito C, Hornykiewicz O (1985) Glutathione peroxidase activity in Parkinson's disease brain. Neurosci Lett 58: 343-346
23. Liang LP, Zigmond MJ (1993) Dopamine synthesis in neostriatal slices after intraventricular 6-hydroxydopamine. Soc Neurosci Abstr 19: 401
24. Liang LP, Hastings TG, Zigmond MJ (1994) Hydroxyl radical formation is increased in rat striatum after L-DOPA treatment. Soc Neurosci Abstr 20: 413
25. Michel PP, Hefti F (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res 26: 428-435
26. Perry TL, Godin DV, Hansen S (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33: 305-310
27. Robinson TE, Whishaw IQ (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res 450: 209-224